Galectin Therapeutics Inc (GALT)

Finanzdaten der Galectin Therapeutics Inc-Aktie (GALT)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	1.81% 9.166	9.003	10.34	10.63	8.122
Interest Income/Expense	28.46% 0.835	0.65	0.46	0.308	0.269
Operating Income/Loss	1.81% -9.166	-9.003	-10.34	-10.63	-8.122
Nonoperating Income/Loss	1,037% -1.262	-0.111	-1.185	-0.001	-0.475
Income/Loss From Continuing Operations Before Tax	14.42% -10.43	-9.114	-11.53	-10.63	-8.597
Income/Loss From Continuing Operations After Tax	14.42% -10.43	-9.114	-11.53	-10.63	-8.597
Net Income/Loss	14.42% -10.43	-9.114	-11.53	-10.63	-8.597
Preferred Stock Dividends And Other Adjustments	109.52% -0.006	0.063	-	0.065	-0.016
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.20% 59.70	59.58	59.48	0.011	59.40
Diluted Average Shares	0.20% 59.70	59.58	59.48	0.011	59.40
Basic Earnings Per Share	60.00% -0.24	-0.15	-0.19	-0.18	-0.14
Diluted Earnings Per Share	60.00% -0.24	-0.15	-0.19	-0.18	-0.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	109.52% -0.006	0.063	-	0.065	-0.016